Bruce G. Allen Investments, LLC Biogen Inc. Transaction History
Bruce G. Allen Investments, LLC
- $129 Billion
- Q3 2024
A detailed history of Bruce G. Allen Investments, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Bruce G. Allen Investments, LLC holds 37 shares of BIIB stock, worth $6,452. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37
Previous 56
33.93%
Holding current value
$6,452
Previous $13 Million
44.75%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding BIIB
# of Institutions
1,017Shares Held
128MCall Options Held
1.22MPut Options Held
1.4M-
Vanguard Group Inc Valley Forge, PA16.6MShares$2.9 Billion0.08% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.85 Billion2.78% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.54 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.1MShares$1.24 Billion0.07% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.68MShares$990 Million0.83% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $25.1B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...